Skip to main content
Top

Clinical & Experimental Metastasis

Issue 1/2005

Content (10 Articles)

Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis

Eugene P. Toy, Nathalie Bonafé, Asim Savlu, Caroline Zeiss, Wenxin Zheng, Maryann Flick, Setsuko K. Chambers

Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer

Michael I. Koukourakis, Alexandra Giatromanolaki, Costantinos Simopoulos, Alexandros Polychronidis, Efthimios Sivridis

Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells

Shunsuke Fukumoto, Masayo Morifuji, Yoshinori Katakura, Masamichi Ohishi, Seiji Nakamura

Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow

Neslihan Cabioglu, Aysegul Sahin, Michele Doucet, Ekrem Yavuz, Abdullah Igci, Engin O.Yildirim, Esin Aktas, Sema Bilgic, Bayram Kiran, Gunnur Deniz, Janet E. Price

Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior

Alexander D. Borowsky, Ruria Namba, Lawrence J.T. Young, Kent W. Hunter, J. Graeme Hodgson, Clifford G. Tepper, Erik T. McGoldrick, William J. Muller, Robert D. Cardiff, Jeffrey P. Gregg

Identification of molecular markers for metastasis-related genes in primary breast cancer cells

Koshi Mimori, Akemi Kataoka, Keiji Yoshinaga, Mitsuhiko Ohta, Yasuaki Sagara, Yasuji Yoshikawa, Shinji Ohno, Graham F. Barnard, Masaki Mori

Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest

Bíborka Bereczky, Réka Gilly, Erzsébet Rásó, Ágnes Vágó, József Tímár, József Tóvári

Frequent loss of membranous E-cadherin in gastric cancers: A cross-talk with Wnt in determining the fate of β-catenin

Xiao-Xin Cheng, Zi-Chuang Wang, Xiao-Yan Chen, Yuan Sun, Qing-You Kong, Jia Liu, Xue Gao, Hong-Wei Guan, Hong Li

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine